Thia st. Martin

Thia St. Martin currently holds the position of Principal Scientist at Seamless Therapeutics, a role commenced in April 2024. Prior to this, Thia worked as a Consultant specializing in Covalent Drug Assays at Dunad Therapeutics for a brief period in March and April 2024. From April 2016 to September 2023, Thia served as Principal Scientist at Homology Medicines Inc. Furthermore, Thia's earlier experience includes a tenure as Scientist II at Celgene Avilomics Research from November 2007 to January 2016, and as Principal Research Associate at Genzyme from 2004 to 2007.